drugset
drugset / Trial / NCT04138849

Evaluate Safety, Pharmacokinetics and Pharmacodynamics of BBT-877 in Healthy Japanese Male

NCT04138849 ↗

Phase 1 Completed 24 enrolled Bridge Biotherapeutics, Inc. KCRN Research, LLC · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study will collect safety, pharmacokinetic, and pharmacodynamic data in Japanese male subjects in order to support development worldwide.

Timeline

Start
2019-10-01
Primary completion
2019-10-25
Completion
2019-10-25

Drugs

EvaluationDrugModalityDoseRoute
Subject BBT-877 Unknown — Oral

Indications

No indication recorded.